The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer

Published:2013-12 Issue:1 Volume:13 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Huang Ching-Wen,Tsai Hsiang-Lin,Chen Yi-Ting,Huang Chun-Ming,Ma Cheng-Jen,Lu Chien-Yu,Kuo Chao-Hung,Wu Deng-Chyang,Chai Chee-Yin,Wang Jaw-Yuan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-13-599.pdf

Reference39 articles.

1. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2013. CA Cancer J Clin. 2013, 63: 11-30. 10.3322/caac.21166.

2. Department of health, the Executive Yuan, Republic of China: Health and vital statistics. http://www.mohw.gov.tw/cht/DOS/Index.aspx,

3. Teufel A, Steinmann S, Siebler J, Zanke C, Hohl H, Adami B, Schroeder M, Klein O, Höhler T, Galle PR, Heike M, Moehler M: Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer. BMC Cancer. 2004, 4: 38-10.1186/1471-2407-4-38.

4. Folprecht G, Lutz MP, Schöffski P, Seufferlein T, Nolting A, Pollert P, Köhne CH: Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Ann Oncol. 2006, 17: 450-456. 10.1093/annonc/mdj084.

5. Ciardiello F, Tortora G: EGFR antagonists in cancer treatment. N Engl J Med. 2008, 358: 1160-1174. 10.1056/NEJMra0707704.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target;Cell Death Discovery;2023-10-28

2. Metachronous colorectal cancer metastasis: Who, what, when and what to do about it;Journal of Surgical Oncology;2023-07-17

3. Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer;Frontiers in Oncology;2022-09-23

4. Which patients are prone to suffer liver metastasis? A review of risk factors of metachronous liver metastasis of colorectal cancer;European Journal of Medical Research;2022-07-25

5. Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy;Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics;2021-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3